ASRT - Assertio Holdings, Inc.

Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Market Cap

$151.9M

Beta

0.53

52-Week Range

8.61-23.5

CEO

Mark L. Reisenauer

Employees

58

IPO Date

Dec 3, 1997

Exchange

NASDAQ

ASRT Options Snapshot

Options pricing data for ASRT is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.

What This Page Covers

The ASRT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.